PIK3CB and head and neck squamous cell carcinoma: Similarly, a very high rate of PI3K pathway mutations (>50–60% cases) in HPV(+) HNSCC clearly implicates the importance of PI3K activation in HPV-mediated HNSCC oncogenesis.